Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction

BackgroundThe identification of known mutations in a cell population is important for clinical applications and basic cancer research. In this work an immobilized form of the polymerase chain reaction, referred to as polony technology, was used to detect mutations as well as gene deletions, resulting in loss of heterozygosity (LOH), in cancer cell lines. Specifically, the mutational hotspots in p53, namely codons 175, 245, 248, 249, 273, and 282, and K-ras2, codons 12, 13 and 61, were genotyped in the pancreatic cell line, Panc-1. In addition LOH analysis was also performed for these same two genes in Panc-1 by quantifying the relative gene copy number of p53 and K-ras2.ResultsUsing polony technology, Panc-1 was determined to possess only one copy of p53, which possessed a mutation in codon 273, and two copies of K-ras2, one wildtype and one with a mutation in codon 12. To further demonstrate the general approach of this method, polonies were also used to detect K-ras2 mutations in the pancreatic cell lines, AsPc-1 and CAPAN-1.ConclusionsIn conclusion, we have developed an assay that can detect mutations in hotspots of p53 and K-ras2 as well as diagnose LOH in these same genes.

[1]  F. Real,et al.  Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer , 1994, International journal of cancer.

[2]  Ying Wang,et al.  Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation , 2002, Journal of Gastroenterology.

[3]  L. Pradayrol,et al.  Identification of K-ras Mutations in Pancreatic Juice in the Early Diagnosis of Pancreatic Cancer , 1995, Annals of Internal Medicine.

[4]  T. Okai,et al.  Usefulness of Supernatant of Pancreatic Juice for Genetic Analysis of K-ras in Diagnosis of Pancreatic Carcinoma , 2001, Pancreas.

[5]  G. Church,et al.  In situ localized amplification and contact replication of many individual DNA molecules. , 1999, Nucleic acids research.

[6]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[7]  J. Groffen,et al.  c-K-ras mutations in human carcinomas occur preferentially in codon 12. , 1987, Oncogene.

[8]  H. Kijima,et al.  Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines. , 2001, Oncology reports.

[9]  H. Saisho,et al.  Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. , 1993, Cancer research.

[10]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[11]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[12]  K. Kinzler,et al.  Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[14]  G. Cooper,et al.  Cellular transforming genes. , 1982, Science.

[15]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[16]  G. Adessi,et al.  Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice , 2001, American Journal of Gastroenterology.

[17]  C. Harris,et al.  1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. , 1995, Toxicology letters.

[18]  J. Hoeijmakers Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[19]  F. Real,et al.  Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.

[20]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[21]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[22]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[23]  David E. Housman,et al.  Digital genotyping and haplotyping with polymerase colonies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Hruban,et al.  Loss of heterozygosity or intragenic mutation, which comes first? , 2001, The American journal of pathology.

[25]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.